Asia Pacific Vaccines Market worth $14.57 billion by 2030
The report "Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030", is projected to reach USD 14.57 billion by 2030, from USD 9.46 billion in 2025, with a CAGR of 9.0%.
Browse 310 market data Tables and 25 Figures spread through 290 Pages and in-depth TOC on "Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-vaccines-market-132686122.html
The Asia Pacific vaccines market is experiencing significant growth, driven by several factors, including advancements in vaccine development technologies and increased healthcare expenditure.
By type, multivalent vaccines secured the leading position in 2024.
In 2024, multivalent vaccines held the largest market share, mainly because of simplified schedules that target multiple strains (e.g., hexavalent DTP-Hib-HepB) in a single shot for pediatric programs. Cost savings, fewer clinic visits, and better compliance in high-burden countries like India and Indonesia drive their dominance, supported by Serum Institute’s scalable production.
By route of administration, the intramuscular & subcutaneous segment is expected to record the highest CAGR during the forecast period.
During the forecast period, intramuscular & subcutaneous administration is expected to be the fastest-growing segment, driven by the increasing adoption of mRNA boosters and adjuvanted shots for influenza and shingles. This method offers precise dosing for aging populations in Japan and China, with needle-free innovations accelerating uptake amid expanded adult immunization efforts.
China dominated the Asia Pacific market in 2024.
China acquired the highest market share in 2024, propelled by extensive state-driven immunization programs, advanced domestic production capabilities, and prominent manufacturers like Sinovac and Walvax. Sophisticated infrastructure, Healthy China 2030 policies, and primary R&D hubs in Beijing and Shanghai accelerate comprehensive pediatric and adult vaccination schedules for key diseases.
Key market players include Serum Institute of India (India), Pfizer Inc. (US), Merck & Co., Inc. (US), GSK (UK), Bharat Biotech (India), Panacea Biotec (India), Biological E Limited (India), and Mitsubishi Tanabe Pharma Corporation (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Vaccines Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
